Molecular mechanisms of neuroinflammationin Alzheimer's disease

Neuroinflammation: Pathogenesis, Mechanisms and Management

Volumn , Issue , 2012, Pages 47-64

  Vukic, Vanja ^a,b   Callaghan, Debbie ^a   Liu, Hong ^a   Zhang, Wandong ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895264062     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (120)

1. Selkoe, D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81: 741-766.
2. Zlokovic, B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57: 178-201.
3. Selkoe, D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 2008, 192: 106-113.
4. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y., LaFerla, F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39: 409-421.
5. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21: 383-421.
6. Tuppo, E.E., Arias, H.R. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Boil 2005, 37: 289-305.
7. Craft, J.M., Watterson, D.M., Van Eldik, L.J. Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 2006, 53: 484-490.
8. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009, 41: 1088-1093.
9. Jones, L., Holmans, P.A., Hamshere, M.L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010, 5: e13950.
10. Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J.C., Carrasquillo, M.M., Abraham, R., Hamshere, M.L., Pahwa, J.S., Moskvina, V., et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011, 43: 429-435.
11. Griffin, W.S., Sheng, J.G., Roberts, G.W., Mrak, R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995, 54: 276-281.
12. Grammas, P., Ovase, R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 2001, 22: 837-842.
13. McGeer, P.L., McGeer, E.G. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 2004, 1035: 104-116.
14. Vukic, V., Callaghan, D., Walker, D., Lue, L.F., Liu, Q.Y., Couraud, P.O., Romero, I.A., Weksler, B., Stanimirovic, D.B., Zhang, W. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 2009, 34: 95-106.
15. Meda, L., Cassatella, M.A., Szendrei, G.I., Otvos, L., Jr., Baron, P., Villalba, M., Ferrari, D., Rossi, F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374: 647-650.
16. Walker, D.G., Lue, L.F., Beach, T.G. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging 2001, 22: 957-966.
17. Walker, D.G., Link, J., Lue, L.F., Dalsing-Hernandez, J.E., Boyes, B.E. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J Leukoc Biol 2006, 79: 596-610.
18. Lue, L.F., Kuo, Y.M., Beach, T., Walker, D.G. Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol 2010, 41: 115-128.
19. Haga, S., Akai, K., Ishii, T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 1989, 77: 569-575.
20. Mackenzie, I.R., Hao, C., Munoz, D.G. Role of microglia in senile plaque formation. Neurobiol Aging 1995, 16: 797-804.
21. Murphy, G.M., Jr., Yang, L., Cordell, B. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J Biol Chem 1998, 273: 20967-20971.
22. Araujo, D.M., Cotman, C.W. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 1992, 569: 141-145.
23. Chao, C.C., Hu, S., Kravitz, F.H., Tsang, M., Anderson, W.R., Peterson, P.K. Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury. Mol Chem Neuropathol 1994, 23: 159-178.
24. McDonald, D.R., Brunden, K.R., Landreth, G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci 1997, 17: 2284-2294.
25. McDonald, D.R., Bamberger, M.E., Combs, C.K., Landreth, G.E. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998, 18: 4451-4460.
26. Combs, C.K., Johnson, D.E., Cannady, S.B., Lehman, T.M., Landreth, G.E. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci 1999, 19: 928-939.
27. Combs, C.K., Johnson, D.E., Karlo, J.C., Cannady, S.B., Landreth, G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 2000, 20: 558-567.
28. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103: 239-252.
29. Bamberger, M.E., Landreth, G.E. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease. Microsc Res Tech 2001, 54: 59-70.
30. Zlokovic, B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005, 28: 202-208.
31. Cirrito, J.R., Deane, R., Fagan, A.M., Spinner, M.L., Parsadanian, M., Finn, M.B., Jiang, H., Prior, J.L., Sagare, A., Bales, K.R., et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 2005, 115: 3285-3290.
32. Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., Mullan, M. Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res 1998, 807: 110-117.
33. Kinnecom, C., Lev, M.H., Wendell, L., Smith, E.E., Rosand, J., Frosch, M.P., Greenberg, S.M. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007, 68: 1411-1416.
34. Atwood, C.S., Scarpa, R.C., Huang, X., Moir, R.D., Jones, W.D., Fairlie, D.P., Tanzi, R.E., Bush, A.I. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem 2000, 75: 1219-1233.
35. Rottkamp, C.A., Raina, A.K., Zhu, X., Gaier, E., Bush, A.I., Atwood, C.S., Chevion, M., Perry, G., Smith, M.A. Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 2001, 30: 447-450.
36. Atamna, H. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease. J Alzheimers Dis 2006, 10: 255-266.
37. Atamna, H., Boyle, K. Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease. Proc Natl Acad Sci USA 2006, 103: 3381-3386.
38. Atamna, H., Frey, W.H., 2nd. A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci USA 2004, 101: 11153-11158.
39. Atamna, H., Frey, W.H., 2nd. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 2007, 7: 297-310.
40. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995, 270: 16483-16486.
41. Karin, M., Liu, Z., Zandi, E. AP-1 function and regulation. Curr Opin Cell Boil 1997, 9: 240-246.
42. Hai, T., Curran, T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 1991, 88: 3720-3724.
43. Waetzig, V., Czeloth, K., Hidding, U., Mielke, K., Kanzow, M., Brecht, S., Goetz, M., Lucius, R., Herdegen, T., Hanisch, U.K. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia, 2005 50: 235-246.
44. Thakur, A., Wang, X., Siedlak, S.L., Perry, G., Smith, M.A., Zhu, X. c-Jun phosphorylation in Alzheimer disease. J Neurosci Res 2007, 85: 1668-1673.
45. Whitmarsh, A.J., Davis, R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996, 74: 589-607.
46. Reynolds, C.H., Betts, J.C., Blackstock, W.P., Nebreda, A.R., Anderton, B.H. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 2000, 74: 1587-1595.
47. Pearson, A.G., Byrne, U.T., MacGibbon, G.A., Faull, R.L., Dragunow, M. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains. Neurosci Lett 2006, 398: 246-250.
48. Bozyczko-Coyne, D., O'Kane, T.M., Wu, Z.L., Dobrzanski, P., Murthy, S., Vaught, J.L., Scott, R.W. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. J Neurochem 2001, 77: 849-863.
49. Morishima, Y., Gotoh, Y., Zieg, J., Barrett, T., Takano, H., Flavell, R., Davis, R.J., Shirasaki, Y., Greenberg, M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001, 21: 7551-7560.
50. Troy, C.M., Rabacchi, S.A., Xu, Z., Maroney, A.C., Connors, T.J., Shelanski, M.L., Greene, L.A. beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem 2001, 77: 157-164.
51. Wei, W., Wang, X., Kusiak, J.W. Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 2002, 277: 17649-17656.
52. Minogue, A.M., Schmid, A.W., Fogarty, M.P., Moore, A.C., Campbell, V.A., Herron, C.E., Lynch, M.A. Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta? J Biol Chem 2003, 278: 27971-27980.
53. Zhu, X., Castellani, R.J., Takeda, A., Nunomura, A., Atwood, C.S., Perry, G., Smith, M.A. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech Ageing Dev 2001, 123: 39-46.
54. Zhu, X., Ogawa, O., Wang, Y., Perry, G., Smith, M.A. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease. J Neurochem 2003, 85: 87-93.
55. Giri, R.K., Selvaraj, S.K., Kalra, V.K. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol 2003, 170: 5281-5294.
56. Callaghan, D., V. Vukic, S. Giuseppin, J. Jones, D. Walker, L-F. Lue, J. Woulfe, N. Chang, TG. Beach, L. Sue, D. Stanimirovic, W. Zhang. Expression and regulation of inflammatory genes in human cerebrovascular endothelial cells induced by Abeta peptides. In Alzheimer's Disease: New Advances. (Bologna, Italy), 2007, pp. 83-87.
57. Verdier, Y., Zarandi, M., Penke, B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci 2004, 10: 229-248.
58. Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., Makita, Z. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res 2001, 888: 256-262.
59. Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382: 685-691.
60. Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A.M., Stern, D., Kim, K.S., Zlokovic, B., Kalra, V.K. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol 2000, 279: C1772-1781.
61. Hommes, D., van den Blink, B., Plasse, T., Bartelsman, J., Xu, C., Macpherson, B., Tytgat, G., Peppelenbosch, M., Van Deventer, S. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 2002, 122: 7-14.
62. Han, Z., Boyle, D.L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A.M., Firestein, G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001, 108: 73-81.
63. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., Kasaoka, T. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 2003, 550: 107-113.
64. Goebeler, M., Gillitzer, R., Kilian, K., Utzel, K., Brocker, E.B., Rapp, U.R., Ludwig, S. Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 2001, 97: 46-55.
65. Klampfer, L., Lee, T.H., Hsu, W., Vilcek, J., Chen-Kiang, S. NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1. Mol Cell Biol 1994, 14: 6561-6569.
66. Gitter, B.D., Cox, L.M., Rydel, R.E., May, P.C. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci USA 1995, 92: 10738-10741.
67. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., Berger, M. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 1991, 285: 111-114.
68. Hull, M., Strauss, S., Berger, M., Volk, B., Bauer, J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 1996, 78: 37-41.
69. Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M., Volk, B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992, 66: 223-230.
70. Wood, J.A., Wood, P.L., Ryan, R., Graff-Radford, N.R., Pilapil, C., Robitaille, Y., Quirion, R. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res 1993, 629: 245-252.
71. Ganter, U., Strauss, S., Jonas, U., Weidemann, A., Beyreuther, K., Volk, B., Berger, M., Bauer, J. Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein. FEBS Lett 1991, 282: 127-131.
72. Brugg, B., Dubreuil, Y.L., Huber, G., Wollman, E.E., Delhaye-Bouchaud, N., Mariani, J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci USA 1995, 92: 3032-3035.
73. Del Bo, R., Angeretti, N., Lucca, E., De Simoni, M.G., Forloni, G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett 1995, 188: 70-74.
74. Blum-Degen, D., Muller, T., Kuhn, W., Gerlach, M., Przuntek, H., Riederer, P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 1995, 202: 17-20.
75. Zhang, W., Stanimirovic, D. Current and future therapeutic strategies to target inflammation in stroke. Curr Drug Targets Inflamm Allergy 2002, 1: 151-166.
76. Baeuerle, P.A., Baltimore, D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242: 540-546.
77. Beg, A.A., Baldwin, A.S., Jr. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev 1993, 7: 2064-2070.
78. Brockman, J.A., Scherer, D.C., McKinsey, T.A., Hall, S.M., Qi, X., Lee, W.Y., Ballard, D.W. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 1995, 15: 2809-2818.
79. Udalova, I.A., Mott, R., Field, D., Kwiatkowski, D. Quantitative prediction of NF-kappa B DNA-protein interactions. Proc Natl Acad Sci USA 2002, 99: 8167-8172.
80. Yamamoto, Y., Gaynor, R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001, 107: 135-142.
81. Murayama, T., Ohara, Y., Obuchi, M., Khabar, K.S., Higashi, H., Mukaida, N., Matsushima, K. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1-and NF-kappaB-binding sites of the interleukin-8 gene. J Virol 1997, 71: 5692-5695.
82. Chong, I.W., Lin, S.R., Hwang, J.J., Huang, M.S., Wang, T.H., Tsai, M.S., Hou, J.J., Paulauskis, J.D. Expression and regulation of macrophage inflammatory protein-2 gene by vanadium in mouse macrophages. Inflammation 2000, 24: 127-139.
83. Walpen, S., Beck, K.F., Schaefer, L., Raslik, I., Eberhardt, W., Schaefer, R.M., Pfeilschifter, J. Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J 2001, 15: 571-573.
84. Jaramillo, M., Olivier, M. Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase-and cyclic adenosine 5'-monophosphate (cAMP)-dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein. J Immunol 2002, 169: 7026-7038.
85. Xiong, H., Callaghan, D., Jones, A., Walker, D.G., Lue, L.F., Beach, T.G., Sue, L.I., Woulfe, J., Xu, H., Stanimirovic, D.B., et al. Cholesterol retention in Alzheimer's brain is responsible for high beta-and gamma-secretase activities and Abeta production. Neurobiol Dis 2008, 29: 422-437.
86. Du Yan, S., Zhu, H., Fu, J., Yan, S.F., Roher, A., Tourtellotte, W.W., Rajavashisth, T., Chen, X., Godman, G.C., Stern, D., et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 1997, 94: 5296-5301.
87. Davis, J., Xu, F., Deane, R., Romanov, G., Previti, M.L., Zeigler, K., Zlokovic, B.V., Van Nostrand, W.E. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 2004, 279: 20296-20306.
88. Ata, A.K., Funa, K., Olsson, Y. Expression of various TGF-beta isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 1997, 93: 326-333.
89. Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D., Lue, L.F., Stanimirovic, D., et al. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. J Neurosci 2009, 29: 5463-5475.
90. Zhang, W., Mojsilovic-Petrovic, J., Andrade, M.F., Zhang, H., Ball, M., Stanimirovic, D.B. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 2003, 17: 2085-2087.
91. Shen, S., Callaghan, D., Juzwik, C., Xiong, H., Huang, P., Zhang, W. ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease. J Neurochem 2010, 114: 1590-1604.
92. Brechbuhl, H.M., Gould, N., Kachadourian, R., Riekhof, W.R., Voelker, D.R., Day, B.J. Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2. J Biol Chem 2010, 285: 16582-16587.
93. Krishnamurthy, P., Ross, D.D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K.E., Sarkadi, B., Sorrentino, B.P., Schuetz, J.D. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004, 279: 24218-24225.
94. Krishnamurthy, P., Xie, T., Schuetz, J.D. The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther 2007, 114: 345-358.
95. Shaywitz, A.J., Greenberg, M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999, 68: 821-861.
96. Mayr, B., Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001, 2: 599-609.
97. Sakamoto, K.M., Frank, D.A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin Cancer Res 2009, 15: 2583-2587.
98. Saraiva, M., O'Garra, A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10: 170-181.
99. Ananieva, O., Darragh, J., Johansen, C., Carr, J.M., McIlrath, J., Park, J.M., Wingate, A., Monk, C.E., Toth, R., Santos, S.G., et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 2008, 9: 1028-1036.
100. Saura, C.A., Valero, J. The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev Neurosci 2011, 22: 153-169.
101. Sakamoto, K., Karelina, K., Obrietan, K. CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem 2011, 116: 1-9.
102. Klee, C.B., Ren, H., Wang, X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1998, 273: 13367-13370.
103. Crabtree, G.R., Olson, E.N. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109 Suppl, S67-79.
104. Cai, T., Li, X., Ding, J., Luo, W., Li, J., Huang, C. A Cross-Talk Between NFAT and NF-kappaB Pathways is Crucial for Nickel-Induced COX-2 Expression in Beas-2B Cells. Curr Cancer Drug Targets 2011, 11: 548-559.
105. Abdul, H.M., Sama, M.A., Furman, J.L., Mathis, D.M., Beckett, T.L., Weidner, A.M., Patel, E.S., Baig, I., Murphy, M.P., LeVine, H., 3rd, et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 2009, 29: 12957-12969.
106. Zhang, W. ABC transporters and the molecular biology of the blood-brain barrier. In Trends in Neurosciences 2006, (Beijing: Higher Education Press), pp. 439-457.
107. Mojsilovic-Petrovic, J., Callaghan, D., Cui, H., Dean, C., Stanimirovic, D.B., Zhang, W. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation 2007, 4: 12.
108. Eltzschig, H.K., Carmeliet, P. Hypoxia and inflammation. N Engl J Med 2011, 364: 656-665.
109. Dehne, N., Brune, B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 2009, 315: 1791-1797.
110. Shah, Y.M., Ito, S., Morimura, K., Chen, C., Yim, S.H., Haase, V.H., Gonzalez, F.J. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 2008, 134: 2036-2048, 2048 e2031-2033.
111. Brigati, C., Banelli, B., di Vinci, A., Casciano, I., Allemanni, G., Forlani, A., Borzi, L., and Romani, M. Inflammation, HIF-1, and the epigenetics that follows. Mediators Inflamm, 2010, 263914.
112. Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L.E., Song, W. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 2006, 103: 18727-18732.
113. De Gasperi, R., Sosa, M.A., Dracheva, S., Elder, G.A. Presenilin-1 regulates induction of hypoxia inducible factor-1alpha: altered activation by a mutation associated with familial Alzheimer's disease. Mol Neurodegener 2010, 5: 38.
114. Avramovich-Tirosh, Y., Bar-Am, O., Amit, T., Youdim, M.B., Weinreb, O. Up-regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30. Curr Alzheimer Res 2010, 7: 300-306.
115. Munoz-Fernandez, M.A., Fresno, M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 1998, 56: 307-340.
116. Brabers, N.A., Nottet, H.S. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest 2006, 36: 447-458.
117. Szelenyi, J., Vizi, E.S. The catecholamine cytokine balance: interaction between the brain and the immune system. Ann N Y Acad Sci 2007, 1113: 311-324.
118. Frautschy, S.A., Cole, G.M., Baird, A. Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol 1992, 140: 1389-1399.
119. Frackowiak, J., Wisniewski, H.M., Wegiel, J., Merz, G.S., Iqbal, K., Wang, K.C. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol 1992, 84: 225-233.
120. Kopec, K.K., Carroll, R.T. Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J Neurochem 1998, 71: 2123-2131.